Brief: Chemometec Upgrades FY Revenue, EBITDA Guidance
04/05/2026 14:22
May 4 (Reuters) - Chemometec A/S CHEMM.CO: REPORTS ONE-OFF POSITIVE EBITDA EFFECT OF DKK 15.1 MILLION FROM REVENUE ALLOCATION ADJUSTMENT RAISES 2025/26 REVENUE GUIDANCE TO DKK 505-525 MILLION FROM DKK 490-520 MILLION RAISES 2025/26 EBITDA GUIDANCE TO DKK 275-290 MILLION FROM DKK 260-285 MILLION Source text: ID:nGNE32qbCj Further company coverage: CHEMM.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation